Download Files:
PDE4-IN-14
SKU
HY-155830-Get quote
Category Reference compound
Tags Cancer; Metabolic Disease; Inflammation/Immunology; Neurological Disease, Metabolic Enzyme/Protease, Phosphodiesterase (PDE)
Products Details
Product Description
– PDE4-IN-14 (Compound 1) is a PDE4 inhibitor that can be used in the study of PDE4-related diseases (such as inflammatory and immune diseases, cancer, and metabolic diseases, etc.)[1].
Web ID
– HY-155830
Shipping
– Room temperature
Molecular Formula
– C19H20F2N4O3S
References
– [1]Ko KUMURA, et al. Crystal of benzoxazole derivative. Patent CA3104829A1.
CAS Number
– 2231329-25-0
Molecular Weight
– 422.45
SMILES
– FC(OC1=C2N=C(N3CC4NC(C4)C3)OC2=C(C5=NC=CS5)C=C1)(C(C)(C)O)F
Clinical Information
– No Development Reported
Research Area
– Cancer; Metabolic Disease; Inflammation/Immunology; Neurological Disease
Solubility
– 10 mM in DMSO
Target
– Phosphodiesterase (PDE)
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.